Originally published in Pharma’s Almanac The healthcare burden of cancer is increasing worldwide. There were an estimated 18 million new cancer cases in 2018,1 a 28% annual increase from 2012. Alarmingly, by 2030, annual diagnoses are expected to increase another 31%
Is the U.S. Biosimilars Market Poised for Takeoff?
Originally published in Pharma’s Almanac The biosimilars market in the United States continues to lag behind the rest of the world. However, there are promising signs that the market is poised to gain momentum. Expanding Biosimilars Market Given biologics’ complexity,
4 Questions on Our Minds as We Head to Chemspec Europe 2019
Chemspec Europe is an event that the Haig Barrett team looks forward to each year. With nearly 350 exhibitors from 27 countries, this gathering is a bellwether of sorts for the European specialty chemical industry. So what will we be
Leaders of Transformation
Haig Armaghanian Leads the Conversation with Synthetic Biology Executives Revolutionizing Therapeutic Development The therapeutic breakthroughs that are hitting the pages of scientific publications and news media outlets almost every day can make it feel as though this revolutionary medical progress
The Evolution of API Route Decisions
How advancements in biocatalytic capabilities have added to the API development and manufacturing toolbox Until recently, pharmaceutical active product ingredient (API) developers were limited to selecting from a roster of chemical catalysts to perform the transformations needed for drug manufacturing.
Increasing the Speed of the Synthetic Biology Design-Build-Test-Learn Pipeline
The synthetic biology field has the power to revolutionize many industries including chemicals, food, material science, molecular biology, pharmaceuticals, biotherapeutics, and many others. Synthetic biology has come a long way, and the very cost-effective ability to read and write DNA
Emily Leproust Discusses Synthetic Biology’s Role in Transforming Therapeutics
The rapidly developing field of synthetic biology has the power to revolutionize many industries including chemicals, food, material science, molecular biology, pharmaceuticals, biotherapeutics, and many others. While numerous fields will and are benefiting from synthetic biology advancements, the medical and
2019 Has Arrived. So, What’s Ahead for the Biopharmaceutical Industry?
by Haig Armaghanian As the new year begins, it’s helpful to look back at 2018 for clues as to what might be ahead. 2018 was a good year for biopharma. Profits were strong, IPO activity was robust, and Takeda’s $62
Engineering Success: Codexis President & CEO Shares Lessons About Corporate Change Management
By Haig Armaghanian, Haig Barrett Management Consultants Given the dynamics of today’s business climate, it might come as no surprise that change management is a topic that emerges constantly as the Haig Barrett team and I interact with executives and
Who Has Had the Biggest Impact On Your Career?
Haig Armaghanian sits down with Mark Sadovnick of Sadovnick Partners, an executive search firm based in Los Angeles, to reflect on who most influenced him over the course of his career. Mark and Haig have a quick, but interesting discussion that